PDF(Sci-hub)
Abstract：
BACKGROUND: Neurological diseases are the leading cause of disability and the second leading cause of death worldwide. Physical and psychological pain, despair, and disconnection with the environment are observed after the diagnosis of numerous neurological processes, particularly neurodegenerative diseases.
METHODS: A higher risk of suicide is observed in patients with such common neurological diseases as epilepsy, migraine, and multiple sclerosis, as well as in those with such degenerative disorders as Alzheimer disease, Huntington disease, amyotrophic lateral sclerosis, and Parkinson\'s disease. In most cases, suicidal ideation appears in the early stages after diagnosis, in the presence of disabling symptoms, and/or in patients with psychiatric comorbidities (often associated with these neurological diseases).
CONCLUSIONS: Effective suicide prevention in this population group requires assessment of the risk of suicide mainly in newly diagnosed patients, in patients showing unmistakable despair or disabling symptoms, and in patients presenting psychiatric comorbidities (especially depressive symptoms). It is essential to train specialists to detect warning signs in order that they may adopt a suitable approach and determine when psychiatric assessment is required.
METHODS: A higher risk of suicide is observed in patients with such common neurological diseases as epilepsy, migraine, and multiple sclerosis, as well as in those with such degenerative disorders as Alzheimer disease, Huntington disease, amyotrophic lateral sclerosis, and Parkinson\'s disease. In most cases, suicidal ideation appears in the early stages after diagnosis, in the presence of disabling symptoms, and/or in patients with psychiatric comorbidities (often associated with these neurological diseases).
CONCLUSIONS: Effective suicide prevention in this population group requires assessment of the risk of suicide mainly in newly diagnosed patients, in patients showing unmistakable despair or disabling symptoms, and in patients presenting psychiatric comorbidities (especially depressive symptoms). It is essential to train specialists to detect warning signs in order that they may adopt a suitable approach and determine when psychiatric assessment is required.
摘要：
背景：神经系统疾病是世界范围内致残的主要原因和第二大死亡原因。身体和心理上的痛苦，绝望,在诊断出许多神经过程后观察到与环境的脱节，特别是神经退行性疾病。
方法：患有癫痫等常见神经系统疾病的患者自杀风险更高，偏头痛,和多发性硬化症，以及患有阿尔茨海默病等退行性疾病的人，亨廷顿病,肌萎缩侧索硬化，和帕金森病。在大多数情况下,自杀意念出现在诊断后的早期阶段，在出现致残症状的情况下，和/或患有精神病合并症（通常与这些神经系统疾病相关）的患者。
结论：在这一人群中有效的自杀预防需要评估主要在新诊断患者中的自杀风险，患者表现出明显的绝望或致残症状，以及出现精神病合并症（尤其是抑郁症状）的患者。培训专家以检测警告标志，以便他们可以采取适当的方法并确定何时需要进行精神病评估，这一点至关重要。
方法：患有癫痫等常见神经系统疾病的患者自杀风险更高，偏头痛,和多发性硬化症，以及患有阿尔茨海默病等退行性疾病的人，亨廷顿病,肌萎缩侧索硬化，和帕金森病。在大多数情况下,自杀意念出现在诊断后的早期阶段，在出现致残症状的情况下，和/或患有精神病合并症（通常与这些神经系统疾病相关）的患者。
结论：在这一人群中有效的自杀预防需要评估主要在新诊断患者中的自杀风险，患者表现出明显的绝望或致残症状，以及出现精神病合并症（尤其是抑郁症状）的患者。培训专家以检测警告标志，以便他们可以采取适当的方法并确定何时需要进行精神病评估，这一点至关重要。
